Corporate Social Responsibility

Adhere To The Principle Of Sustainable Development To Create A Better Life

November 2023

Published Time:

2025-04-24

Introducing a highly selective second-generation Nav1.8 inhibitor, an innovative drug for pain treatment, expected to be highly effective and non-addictive. Health Yuan is responsible for subsequent clinical research and application for production of this drug.